Found: 6
Select item for more details and to access through your institution.
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00885-1
- By:
- Publication type:
- Article
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad417
- By:
- Publication type:
- Article
2712. Safety and Immunogenicity of two Doses of ExPEC4V Vaccine Against Extraintestinal Pathogenic Escherichia coli Disease in Healthy Adult Participants.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S954, doi. 10.1093/ofid/ofz360.2389
- By:
- Publication type:
- Article
Preparation of Erythromycin Analogs Having Functional Groups at C-15.
- Published in:
- Journal of Antibiotics, 2006, v. 59, n. 7, p. 392, doi. 10.1038/ja.2006.56
- By:
- Publication type:
- Article
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.
- Published in:
- Nature Medicine, 2006, v. 12, n. 1, p. 83, doi. 10.1038/nm1347
- By:
- Publication type:
- Article
15-Amido Erythromycins: Synthesis and in Vitro Activity of a New Class of Macrolide Antibiotics.
- Published in:
- Journal of Antibiotics, 2005, v. 58, n. 3, p. 167, doi. 10.1038/ja.2005.19
- By:
- Publication type:
- Article